OR Manager Conference (formerly Managing Today’s OR Suite), brings together more than 1, 400 managers and directors involved in leading the surgical suite for 3 days of continuing education and networking opportunities. The conference builds on the content developed in each issue of OR Manager, providing you with a live learning experience. Earn CEs, AEUs, and explore new technologies with solution providers.
OR Manager Conference provides you with plenty of opportunities to earn contact hours throughout the three days you will spend in Orlando!Learn More
Editor’s Note The Society for Healthcare Epidemiology of America (SHEA) on December 11 published a new expert guidance on “Infection prevention in the operating room anesthesia work area.” Key recommendations of the guidance to improve infection prevention include: Increased hand hygiene performed, at a minimum, before aseptic tasks, after removing gloves, when hands are soiled, […]
The post SHEA issues new guidance on infection control in anesthesiology appeared first on OR Manager.
Editor’s Note US hospital jobs increased 12,700 in November to a seasonally adjusted 5,228,200, the Bureau of Labor Statistics reported on December 7. That is up 118,000 more employees than a year ago. Overall, healthcare employment has increased by 328,300 in the past year. The overall unemployment rate is 3.7%.
The post Hospital jobs up 12,700 in November appeared first on OR Manager.
Editor’s Note In this study, an ultrarestrictive opioid prescribing strategy was associated with a reduction in the number of pills dispensed without changes in postoperative pain, complications, or increases in prescription refill requests. In this case-control 2-year analysis of 1,231 women having surgery for gynecologic cancer, those having ambulatory or minimally invasive procedures weren’t prescribed […]
The post Ultrarestrictive opioid prescription strategy results in fewer pills dispensed, no increase in pain appeared first on OR Manager.
Editor’s Note The Food and Drug Administration (FDA) on December 10 issued a statement on an updated safety communication about rates of duodenoscope contamination obtained from preliminary postmarket data. Interim results from sampling studies from device manufacturers−Olympus, Fujifilm, and Pentax− indicate higher-than-expected contamination rates after reprocessing. Up to 3% of samples tested positive for more […]
The post FDA issues statement on updated rates of duodenoscope contamination appeared first on OR Manager.